There is serious value in DMX at current SP that the market is missing in my view.
Dimerix have repeatedly stated they are taking DMX200 into phase three trials and this looking increasingly likely to happen in 2021.
Costs are relatively low due to orphans designation so any CR will be small.
Chances of success for this drug type is 64%
https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845
With the FSGS market value estimated at up to US$6.7B per year in the US alone, with DMX having exclusivity for ten years in US and 7 years in Europe. https://unauthorised investment advice/health/dimerix-is-tapping-a-potential-multi-billion-dollar-fsgs-market-opportunity/
So once the Phase 3 trial commences, there's a 64% chance DMX takes a drug to market with, lets say a potential A$20B per annum in global revenues?
There is a case for the market cap, right now, to be ten times what it is today. And it will still be a ten bagger on successful phase three results.
Time for the market to wake up.
(sorry title should read Phase 3 clinical study in FSGS in 2021, cant edit)
- Forums
- ASX - By Stock
- DXB
- Phase 3 clinical study in FSGS in the first half of 2021
Phase 3 clinical study in FSGS in the first half of 2021
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 37.0¢ | $503.5K | 1.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26318 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 170072 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1318 | 0.380 |
3 | 72579 | 0.375 |
4 | 134161 | 0.370 |
1 | 30000 | 0.365 |
4 | 27499 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 140963 | 5 |
0.395 | 61740 | 2 |
0.400 | 115000 | 2 |
0.405 | 86528 | 4 |
0.410 | 56400 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |